Join to View Full Profile
3400 Civic Center Blvd2 WestPhiladelphia, PA 19104
Phone+1 215-615-5121
Dr. Marmarelis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Melina Marmarelis is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center. She received her medical degree from Harvard Medical School and has been in practice 4 years. She is experienced in lung cancer and medical education.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
PA State Medical License 2016 - 2026
MA State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- HSR25-167: Real-World Study Demonstrates Lack of Biomarker-driven Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer That Received Next-Ge...Melina E Marmarelis, Adrienne M Gilligan, Tomoko Sugihara, Shen Zheng, Tyler Marquart
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Management of Patients WithExon 20-Mutant Advanced Non-Small Cell Lung Cancer.Lova Sun, Melina E Marmarelis, Charu Aggarwal
Journal of Clinical Oncology. 2025-03-07 - Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC.Margaret Stalker, Melina Marmarelis, Corey Langer, Roger B Cohen, Aditi Singh
Clinical Lung Cancer. 2025-03-01
Press Mentions
Genomic Profile Availability Impact on NSCLC Patient Outcomes in Real World Study and Daily PracticeAugust 22nd, 2024- Pembrolizumab Active in Diffuse Malignant Peritoneal MesotheliomaApril 20th, 2023
- Party with a Purpose Benefits AACR and Supports Lung Cancer ResearchOctober 27th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
